Development and validation of a blocking ELISA for measurement of rabies virus neutralizing antibody., PMID:40366189
Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs., PMID:40354406
Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein., PMID:40284919
Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice., PMID:40266088
Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice., PMID:40251380
Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein., PMID:40154685
Construction and evaluation of recombinant rabies virus encoding three copies codon-optimized G genes as inactivated rabies vaccine in dogs and cats., PMID:40112690
A VSV-based oral rabies vaccine was sentineled by Peyer's patches and induced a timely and durable immune response., PMID:40022445
Metagenomic next-generation sequencing for etiological diagnosis of an unexpected rabies case with unclear exposure history., PMID:39994640
IL-16 exerts anti-rabies virus effects through CD9 on the surface of viral particles., PMID:39956243
Evaluation of the immune status of dogs vaccinated against rabies by an enzyme-linked immunosorbent assay using crude preparations of insect cells infected with a recombinant baculovirus encoding the rabies virus glycoprotein gene., PMID:39625902
Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases., PMID:39604401
Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis., PMID:39601104
IL-7 promotes mRNA vaccine-induced long-term immunity., PMID:39550592
Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold., PMID:39471803
A novel inactivated oral rabies vaccine with the incorporation of U-OMP19 enhances the immunogenicity by reducing viral proteins degradation and activating dendritic cells in a mouse model., PMID:39471657
Analysis of the antigenic and immunogenic properties of the native rabies virus glycoprotein purified by Lens culinaris lectin affinity chromatography., PMID:39413880
Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate., PMID:39366932
A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice., PMID:39129566
Toward the Development of a Pan-Lyssavirus Vaccine., PMID:39066269
Comparison of 4 laboratory tests for the detection of bovine rabies viral infection in Paraguay: fluorescent antibody test, rapid detection test, histologic lesions, and RT-PCR., PMID:38653733
Immune response after oral immunization of goats and foxes with an NDV vectored rabies vaccine candidate., PMID:38408125
A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong cellular and humoral immunity., PMID:38262810
A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs., PMID:38164714
An mRNA vaccine against rabies provides strong and durable protection in mice., PMID:37954577
A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses., PMID:37923181
Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice., PMID:37866995
A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs., PMID:37819147
Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells., PMID:37786447
Genomic Surveillance of Rabies Virus in Georgian Canines., PMID:37766204
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy., PMID:37638057
Characterization of a human-mouse chimeric monoclonal antibody targeting rabies virus glycoprotein., PMID:37493180
Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses., PMID:37349310
Pseudotyped Viruses for Lyssavirus., PMID:36920698
Transferrin Receptor Protein 1 Is an Entry Factor for Rabies Virus., PMID:36779762
A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice., PMID:36761167
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs., PMID:36371169
Development of a reporter gene assay for antibody dependent cellular cytotoxicity activity determination of anti-rabies virus glycoprotein antibodies., PMID:36346082
Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies., PMID:35985336
A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein., PMID:35755997
Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody., PMID:35714192
A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge., PMID:35618603
Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates., PMID:35579916
Point Mutations in the Glycoprotein Ectodomain of Field Rabies Viruses Mediate Cell Culture Adaptation through Improved Virus Release in a Host Cell Dependent and Independent Manner., PMID:34696419
Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs., PMID:34613801
Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model., PMID:34346765
An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens., PMID:34086672
Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice., PMID:33985418
A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice., PMID:33957572
Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization., PMID:33882114